Soligenix
SNGX
#10211
Rank
ยฃ12.31 M
Marketcap
ยฃ1.22
Share price
-0.96%
Change (1 day)
-49.44%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.42. In 2024 the company made an earnings per share (EPS) of -ยฃ3.72 an increase over its 2023 EPS that were of -ยฃ9.46.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.65%
2024-ยฃ3.72-60.66%
2023-ยฃ9.46-83.55%
2022-ยฃ57.5113.95%
2021-ยฃ50.47-56.03%
2020-ยฃ114.7833.33%
2019-ยฃ86.09-29.41%
2018-ยฃ121.96-41.38%
2017-ยฃ208.0524.73%
2016-ยฃ166.80-69%
2015-ยฃ538.05-6.25%
2014-ยฃ573.92-50.77%
2013-ยฃ1,16675.68%
2012-ยฃ663.5968.18%
2011-ยฃ394.57-69.86%
2010-ยฃ1,309-8.75%
2009-ยฃ1,43533.33%
2008-ยฃ1,076-57.14%
2007-ยฃ2,511-46.15%
2006-ยฃ4,66344.44%
2005-ยฃ3,228-40.7%
2004-ยฃ5,444-15.62%
2003-ยฃ6,452-25.52%
2002-ยฃ8,663-80.94%
2001-ยฃ45,451160.89%
2000-ยฃ17,421-40.57%
1999-ยฃ29,313-63.84%
1998-ยฃ81,066601.73%
1997-ยฃ11,552101.7%
1996-ยฃ5,728

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Emergent BioSolutions
EBS
ยฃ1.05-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.77-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ1.29-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.80-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel